Results 21 to 30 of about 13,171 (198)
Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses.
Kostandinos Sideras +19 more
doaj +1 more source
HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160 [PDF]
HVEM is a TNF (tumor necrosis factor) receptor contributing to a broad range of immune functions involving diverse cell types. It interacts with a TNF ligand, LIGHT, and immunoglobulin (Ig) superfamily members BTLA and CD160.
Kim, Kenneth +27 more
core +1 more source
Ocular herpes simplex virus 1 (HSV-1) infection leads to a potentially blinding immunoinflammatory syndrome, herpes stromal keratitis (HSK). Herpesvirus entry mediator (HVEM), a widely expressed tumor necrosis factor (TNF) receptor superfamily member ...
Rebecca G. Edwards +4 more
doaj +1 more source
The herpes virus entry mediator (HVEM) is an immune checkpoint molecule regulating immune response, but its role in tissue repair remains unclear. Here, we reported that HVEM deficiency aggravated hepatobiliary damage and compromised liver repair after 3,
Yanbo Kou +11 more
doaj +1 more source
Epithelial HVEM maintains intraepithelial T cell survival and contributes to host protection. [PDF]
Intraepithelial T cells (IETs) are in close contact with intestinal epithelial cells and the underlying basement membrane, and they detect invasive pathogens.
Charles D. Surh +27 more
core +1 more source
Background: Dysregulation of immune checkpoint molecules leads to immune evasion in human tumours but has become a viable target for tumour therapy. Here, we examined expression of Herpes virus entry mediator (HVEM), an immune checkpoint molecule, in ...
Ming-Zhi Han +10 more
doaj +1 more source
Ocular herpes simplex virus 1 (HSV-1) infection leads to an immunopathogenic disease called herpes stromal keratitis (HSK), in which CD4+ T cell-driven inflammation contributes to irreversible damage to the cornea. Herpesvirus entry mediator (HVEM) is an
Seo J. Park +5 more
doaj +1 more source
CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA. [PDF]
Defining the molecular interactions required to program activated CD8 T cells to survive and become memory cells may allow us to understand how to augment anti-viral immunity.
Rachel Flynn +5 more
doaj +1 more source
Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2
B and T lymphocyte attenuator (BTLA) is an immune checkpoint molecule that mediates the escape of tumor cells from immunosurveillance. Consequently, BTLA and its ligand herpesvirus entry mediator (HVEM) are potentially immunotherapeutic targets. However,
Tian-You Cheng +10 more
doaj +1 more source
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
Because most patients with multiple myeloma (MM) develop resistance to current regimens, novel approaches are needed. Genetically modified, replication-competent oncolytic viruses exhibit high tropism for tumor cells regardless of cancer stage and prior ...
Jayeeta Ghose +17 more
doaj +1 more source

